Abstract
Chemotherapy is used in many cancers. Although many patients display some clinical response, it is often not curative. Selected chemotherapeutics have been previously found to have immune-stimulating properties via various biological mechanisms. With immunotherapy recently showing promising results in some cancers, the next logical step would be to combine the two treatment modalities. However, it is not known how chemotherapy and immunotherapy can be most effectively combined in order to achieve synergy. In this thesis, I explored the potential for combining chemotherapy and immunotherapy, optimising preclinical models, testing the effects of co-medication and identifying the most optimal drug combinations.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Thesis sponsors | |
| Award date | 20 Sept 2019 |
| DOIs | |
| Publication status | Unpublished - 2019 |
Access to Document
- THESIS - DOCTOR OF PHILOSOPHY - ASTON Wayne John - 2019
This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.